Explore the full lineup of Novo Nordisk products, from Ozempic and Wegovy to the Novo Nordisk pill Rybelsus, plus safety facts for US patients.
Novo Nordisk products are prescription medicines made by Novo Nordisk, a Danish pharmaceutical company best known for diabetes and obesity treatments such as Ozempic, Wegovy, and Rybelsus. The catalog also includes long-acting insulins, other GLP-1 receptor agonists, growth hormone therapy, and clotting-factor medicines for rare bleeding disorders. None of these products are sold over the counter in the United States, and each one requires a prescription and ongoing medical supervision.
What Does Novo Nordisk Make?
Novo Nordisk was founded in Denmark in 1923 and is now one of the largest pharmaceutical manufacturers in the world. The company concentrates on two broad areas: diabetes and obesity care, and rare disease.
Its best-known medicines belong to the GLP-1 receptor agonist class, which mimics a gut hormone to help regulate blood sugar and appetite. Novo Nordisk also invests heavily in next-generation obesity and diabetes research, including combination therapies. The table below summarizes the most widely prescribed Novo Nordisk products in the United States.
| Product | Active Ingredient | Primary Use | Form |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | Weekly injection |
| Wegovy | Semaglutide | Chronic weight management | Weekly injection |
| Rybelsus | Semaglutide | Type 2 diabetes | Daily oral tablet |
| Saxenda | Liraglutide | Chronic weight management | Daily injection |
| Victoza | Liraglutide | Type 2 diabetes | Daily injection |
| Tresiba | Insulin degludec | Diabetes | Daily injection |
| NovoLog | Insulin aspart | Diabetes | Mealtime injection |
| Norditropin | Somatropin | Growth hormone deficiency | Daily injection |
| NovoSeven RT | Coagulation factor VIIa | Hemophilia with inhibitors | Injection |
Novo Nordisk Diabetes Products
Diabetes care remains the foundation of Novo Nordisk's business. The company manufactures both insulin and non-insulin injectables, which gives prescribers several ways to lower blood sugar.
- Ozempic (semaglutide): A once-weekly injection approved for type 2 diabetes. It is not FDA-approved for weight loss, although it is sometimes prescribed off-label for that purpose.
- Victoza (liraglutide): A once-daily injection for type 2 diabetes that also carries a cardiovascular benefit in some patients.
- Tresiba (insulin degludec): A long-acting basal insulin that lasts more than 24 hours.
- NovoLog (insulin aspart): A rapid-acting insulin taken at mealtimes.
- Ryzodeg 70/30: A premixed insulin combining degludec and aspart.
Insulin dosing is highly individual. A dose that works for one person can cause dangerous low blood sugar in another, so these products should only be adjusted with a clinician's guidance.
Weight Management and Obesity Products
Wegovy (semaglutide) was approved by the FDA in 2021 for chronic weight management in adults with obesity or with excess weight plus at least one weight-related condition. Saxenda (liraglutide) came earlier and is given as a daily injection.
These medicines are meant to be used alongside a reduced-calorie diet and increased physical activity. They are not cosmetic treatments, and they are not intended for people who are only mildly overweight.
Novo Nordisk products in this category have received intense public attention, which has led to supply shortages and a rise in counterfeit online sellers. Patients should obtain these medicines only through a licensed pharmacy.
The Novo Nordisk Pill: Rybelsus and Oral Options
Rybelsus is the only Novo Nordisk GLP-1 product taken as a daily pill. It contains semaglutide and is FDA-approved for type 2 diabetes, not for weight loss.
Most people searching for a novo nordisk pill are looking for an oral version of Ozempic or Wegovy. Rybelsus is the closest approved option, but it does not work exactly like the injectables: it must be taken on an empty stomach with no more than four ounces of water, and it is absorbed less predictably than an injection.
Novo Nordisk has also developed higher-dose oral semaglutide for obesity, and approval status can change. Patients who want a pill instead of a shot should ask a healthcare professional what is currently available rather than relying on social media claims.
Rare Disease and Specialty Products
Beyond diabetes and obesity, Novo Nordisk sells treatments for bleeding disorders, growth failure, and certain hormone conditions. These products are usually managed by specialists rather than primary care providers.
- NovoSeven RT (coagulation factor VIIa): Controls bleeding in people with hemophilia A or B who have developed inhibitors.
- NovoEight (coagulation factor VIII): Replacement therapy for hemophilia A.
- Norditropin (somatropin): A growth hormone used in children and adults with growth hormone deficiency.
- Vagifem (estradiol): A low-dose vaginal tablet for menopause-related vaginal dryness.
Many of these medicines require regular lab monitoring, and some must be stored refrigerated. Patients should follow the manufacturer's storage and handling instructions exactly.
Safety, Cost, and Access
Novo Nordisk products are FDA-approved when used as prescribed, but approval does not mean risk-free. GLP-1 medicines such as Ozempic, Wegovy, and Saxenda can cause nausea, vomiting, diarrhea, pancreatitis, and gallbladder disease, and they carry a boxed warning about thyroid C-cell tumors seen in rodents.
Insulin can cause hypoglycemia if the dose is too high or a meal is skipped. Growth hormone therapy can affect blood sugar and fluid balance. Patients should not share injection pens or vials, even within a household, because of infection risk.
Cost is a frequent barrier. Monthly list prices for branded Novo Nordisk products can exceed $900 before insurance, although savings programs, Medicare changes, and pharmacy discounts may reduce the out-of-pocket amount.
Novo Nordisk products are prescription-only medicines for specific diagnosed conditions, not general wellness products. A licensed healthcare professional should decide whether any of them is appropriate for you.
How to Verify a Novo Nordisk Product
Counterfeit versions of popular Novo Nordisk products have appeared online, especially GLP-1 injections sold without a prescription. Legitimate products come from a licensed US pharmacy and carry the manufacturer's labeling.
- Check the National Drug Code (NDC) printed on the package.
- Buy only from a state-licensed pharmacy or a verified telehealth provider.
- Look for the Novo Nordisk logo, lot number, and expiration date on the pen or vial.
- Report suspected counterfeits to the FDA's MedWatch program.
Anyone with questions about dosing, side effects, or whether a Novo Nordisk product is right for them should talk with a licensed healthcare professional before starting or stopping treatment.
Frequently Asked Questions
What are Novo Nordisk's most popular products?
Ozempic, Wegovy, and Rybelsus are the most recognized Novo Nordisk products. Ozempic and Rybelsus are approved for type 2 diabetes, while Wegovy is approved for chronic weight management. All three contain the active ingredient semaglutide.
Is there a Novo Nordisk weight loss pill?
Rybelsus is an oral semaglutide, but it is FDA-approved for type 2 diabetes rather than weight loss. Novo Nordisk has developed higher-dose oral semaglutide for obesity, so patients should ask their prescriber what is currently approved. Injectable Wegovy remains the company's main FDA-approved weight management product.
Are Novo Nordisk products safe?
Novo Nordisk products are FDA-approved for specific conditions when prescribed by a healthcare professional, but they carry real risks. GLP-1 medicines can cause nausea, vomiting, pancreatitis, and gallbladder problems, and they have a boxed warning about thyroid tumors in rodents. Insulin can cause hypoglycemia if dosed incorrectly, so medical supervision is essential.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.